Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Johnson and Johnson
Moodys
Mallinckrodt
Colorcon

Last Updated: January 16, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for ABX464


Email this page to a colleague

« Back to Dashboard

What is the drug development status for ABX464?

ABX464 is an investigational drug.

There have been 16 clinical trials for ABX464. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2020.

The most common disease conditions in clinical trials are Ulcer, Colitis, Ulcerative, and Colitis. The leading clinical trial sponsors are Abivax S.A., FLS-RS, and Orion Corporation, Orion Pharma.

There are thirty-five US patents protecting this investigational drug and five hundred and twenty-nine international patents.

Recent Clinical Trials for ABX464
TitleSponsorPhase
Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative ColitisAbivax S.A.Phase 2
Safety and Pharmacokinetics Study in Healthy Japanese VolunteersAbivax S.A.Phase 1
Evaluaton of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464Abivax S.A.Phase 1

See all ABX464 clinical trials

Clinical Trial Summary for ABX464

Top disease conditions for ABX464
Top clinical trial sponsors for ABX464

See all ABX464 clinical trials

US Patents for ABX464

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ABX464 ⤷  Sign up for a Free Trial Compounds useful for treating AIDS ABIVAX (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris, FR) INSTITUT CURIE (Paris, FR) UNIVERSITE DE MONTPELLIER (Montpellier, FR) ⤷  Sign up for a Free Trial
ABX464 ⤷  Sign up for a Free Trial Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13- ,13A- octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-B] [1,3] oxazepine-10-carboxamide GILEAD SCIENCES, INC. (Foster City, CA) ⤷  Sign up for a Free Trial
ABX464 ⤷  Sign up for a Free Trial Solid forms of a toll-like receptor modulator GILEAD SCIENCES, INC. (Foster City, CA) ⤷  Sign up for a Free Trial
ABX464 ⤷  Sign up for a Free Trial Thiocarbamate prodrugs of tofacitinib THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Sign up for a Free Trial
ABX464 ⤷  Sign up for a Free Trial Human immunodeficiency virus neutralizing antibodies Gilead Sciences, Inc. (Foster City, CA) ⤷  Sign up for a Free Trial
ABX464 ⤷  Sign up for a Free Trial Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging ABIVAX (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris, FR) INSTITUT CURIE (Paris, FR) UNIVERSITE DE MONTPELLIER (Montpellier, FR) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for ABX464

Drugname Country Document Number Estimated Expiration Related US Patent
ABX464 Australia AU2010258214 2029-06-12 ⤷  Sign up for a Free Trial
ABX464 Australia AU2010258294 2029-06-12 ⤷  Sign up for a Free Trial
ABX464 Australia AU2010258295 2029-06-12 ⤷  Sign up for a Free Trial
ABX464 Australia AU2015203256 2029-06-12 ⤷  Sign up for a Free Trial
ABX464 Australia AU2017202500 2029-06-12 ⤷  Sign up for a Free Trial
ABX464 Australia AU2019203896 2029-06-12 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Johnson and Johnson
Moodys
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.